FY2025 · period end Dec '25 · from the 10-K filed Feb 26, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $0.84B | $1.02B | $1.13B | $0.92B | $0.66B |
| Gross Profit | $0.38B | $0.45B | $0.49B | $0.40B | $0.29B |
| Operating Income | $0.12B | $0.21B | $0.27B | $0.21B | $0.13B |
| Net Income | $0.12B | $0.20B | $0.25B | — | — |
| EPS (Diluted) | $3.80 | $6.15 | $7.43 | $5.46 | $2.88 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $1.36B | $1.35B | $1.28B | $1.01B | $0.75B |
| Total Liabilities | $0.33B | $0.34B | $0.42B | $0.35B | $0.21B |
| Stockholders' Equity | $1.03B | $1.01B | $0.86B | $0.67B | $0.54B |
| Cash & Equivalents | $0.15B | $0.12B | $0.17B | $0.19B | $0.29B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.12B | $0.14B | $0.16B | $0.22B | $0.15B |
| Capital Expenditures | $0.01B | $0.01B | $0.02B | $0.01B | $0.01B |
| Free Cash Flow | $0.11B | $0.13B | $0.14B | $0.20B | $0.14B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 44.9% | 44.7% | 43.5% | 43.7% | 43.2% |
| Operating Margin | 0.1% | 0.2% | 0.2% | 0.2% | 19.2% |
| Net Margin | 0.1% | 0.2% | 0.2% | 0.2% | — |
| Return on Equity | 11.7% | 21.4% | 32.1% | 30.9% | — |
| Return on Assets | 8.9% | 15.3% | 21.5% | 21.1% | — |
| Debt / Equity | — | — | — | — | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001104659-26-091697 | Aug 6, 2026 | Aug 6, 2026 | Aug 6, 2026 12:41 UTC | EDGAR |
| 10-Q | 0001104659-26-091999 | Jun 30, 2026 | Aug 6, 2026 | Aug 6, 2026 20:10 UTC | EDGAR |
| 10-Q | 0001104659-26-057725 | Mar 31, 2026 | May 8, 2026 | May 8, 2026 16:20 UTC | EDGAR |
| 8-K | 0001104659-26-057147 | May 7, 2026 | May 7, 2026 | May 7, 2026 20:15 UTC | EDGAR |
| 8-K | 0001104659-26-056230 | May 5, 2026 | May 6, 2026 | May 6, 2026 20:01 UTC | EDGAR |
| 8-K | 0001104659-26-027104 | Mar 10, 2026 | Mar 12, 2026 | Mar 12, 2026 20:36 UTC | EDGAR |
| 10-K | 0001104659-26-020461 | Dec 31, 2025 | Feb 26, 2026 | Feb 26, 2026 20:48 UTC | EDGAR |
| 8-K | 0001104659-26-016391 | Feb 17, 2026 | Feb 17, 2026 | Feb 17, 2026 21:06 UTC | EDGAR |
Direct links to SEC EDGAR. ACLS has additional filings available on the SEC site.
6 numbers AXCELIS TECHNOLOGIES INC later changed — same XBRL tag, both filings linked.
Stockholders' Equity Attributable to Parent·As of Dec 31, 2014
Notable restatementwas$168.4M
Revised down in a 10-K.
Stockholders' Equity Attributable to Parent·As of Dec 31, 2013
Notable restatementwas$176M
Revised down in a 10-K.
Stockholders' Equity Attributable to Parent·As of Dec 31, 2015
Notable restatementwas$190.3M
Revised down in a 10-K.
Assets·As of Dec 31, 2015
Notable restatementwas$288.3M
Revised down in a 10-K.
Assets, Current·As of Dec 31, 2015
Notable restatementwas$236.5M
Revised down in a 10-K.
Defined Contribution Plan, Cost·FY 2017
Major restatementwas$500K
Revised up in a 10-K.
ACLS is not the only one.
See every restatement we've found across the market — or get an alert the next time ACLS revises a number.
Restatements are detected by comparing every vintage of a fact across all of AXCELIS TECHNOLOGIES INC's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows ACLS's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling AXCELIS TECHNOLOGIES INC — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on ACLS yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on ACLS and publish the result to your public profile.
Ask about AXCELIS TECHNOLOGIES INC
Continue in Workspace — cited answers on ACLS, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs